Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 8Terminated 6Recruiting 5Unknown 3Active not recruiting 2Suspended 1Not yet recruiting 1No longer available 1Available 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 23Dermatologic 9Tumor-Agnostic 5Thoracic 5Gastrointestinal 4Genitourinary 3Sarcoma 2Gynecologic 1

Conditions

Sarcoma 111Osteosarcoma 41Sarcoma, Ewing 30Rhabdomyosarcoma 28Melanoma 28Neuroblastoma 21Glioblastoma 18Bone Neoplasms 18Rhabdoid Tumor 17Lymphoma, Non-Hodgkin 17Gliosarcoma 16Neoplasms 15Neoplasm Metastasis 15Liposarcoma 15Breast Neoplasms 15Wilms Tumor 14Ovarian Neoplasms 14Glioma 14Medulloblastoma 13Leiomyosarcoma 13Gastrointestinal Stromal Tumors 13Carcinoma, Non-Small-Cell Lung 13Stomach Neoplasms 12Hepatoblastoma 12Colorectal Neoplasms 12Sarcoma, Synovial 11Ependymoma 11Chordoma 11Carcinoma, Renal Cell 11Neurofibrosarcoma 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Squamous Cell × Sarcoma × Clear all
NCT03737734 2026-04-06

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

Alpha Tau Medical LTD.

Phase NA Active not recruiting
30 enrolled
DermatologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Lip Neoplasms, Sarcoma, Kaposi, Skin Neoplasms, Soft Tissue Neoplasms, Tongue Neoplasms

NCT05812027 2025-11-17

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

TScan Therapeutics, Inc.

Active not recruiting
1,150 enrolled
DermatologicGynecologicHead & NeckSarcomaThoracic

Uveal Melanoma, Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡